Overview
Genväg Bio is a Swedish company founded in 2018, headquartered in Lund. Genomic diagnostics at the point of care. The company works with partners across the Nordics and Europe, combining domain engineering with a sustainability-first operating model. Genväg Bio is recognized within its sector for disciplined execution and long-term customer relationships.
Founded
2018
Employees
5 000+
Revenue
23.3 bn SEK
Headquarters
Lund
CEO
Sofia Rehn
Website
www.genvagbio.se
Featured projects
| Project | Value | Year | Status |
|---|---|---|---|
Imaging AI Trial A multi-site clinical validation of an AI radiology assistant. | 610 M SEK | 2023 | Completed |
Remote Monitoring A connected-care rollout for chronic-condition patients at home. | 870 M SEK | 2023 | Completed |
Implant Manufacturing Certified additive manufacturing of patient-specific implants. | 2830 M SEK | 2023 | Planning |
Products & services
Genväg Diagnostic Suite
AI-assisted diagnostics for clinicians.
Genväg Care Platform
Remote monitoring and connected-care workflows.
Genväg Medical Device
Certified device for clinical and home use.